BNP Paribas Financial Markets’s Genelux GNLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$771 Sell
256
-7,623
-97% -$21.6K ﹤0.01% 5629
2026
Q1
$19.1K Buy
7,879
+46
+0.6% +$125 ﹤0.01% 5100
2025
Q4
$34.2K Buy
7,833
+3,386
+76% +$18.3K ﹤0.01% 4851
2025
Q3
$18.7K Buy
4,447
+4,140
+1,349% +$14.7K ﹤0.01% 4916
2025
Q2
$881 Hold
307
﹤0.01% 5158
2025
Q1
$829 Sell
307
-100
-25% -$375 ﹤0.01% 5092
2024
Q4
$961 Buy
+407
New +$1.08K ﹤0.01% 5084

Other funds holding GNLX

BNP Paribas Financial Markets's GNLX Position: Q2 2026 in Review

BNP Paribas Financial Markets reduced its Genelux (GNLX) stake by 97% in Q2 2026, selling an estimated $21.6K and leaving 256 shares worth $771. The position accounts for ﹤0.01% of the portfolio, ranked #5629.

BNP Paribas Financial Markets first reported a position in GNLX in Q4 2024 and has held it in 7 quarters since. The position peaked at $34.2K in Q4 2025. 70 funds tracked by Wall St. Rank hold GNLX as of Q2 2026.

  • BNP Paribas Financial Markets held 256 shares of Genelux worth $771 as of Q2 2026.
  • BNP Paribas Financial Markets sold 7,623 Genelux shares in Q2 2026, an estimated $21.6K.
  • Genelux made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #5629 holding.
  • BNP Paribas Financial Markets first reported a position in Genelux in Q4 2024 and has held it in 7 quarters since.
  • BNP Paribas Financial Markets's Genelux position peaked at $34.2K in Q4 2025.
  • 70 funds tracked by Wall St. Rank held Genelux as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.